跳至主要内容
临床试验/NL-OMON47575
NL-OMON47575已完成2 期

Treatment of central sleep apnoea and Cheyne Stokes respiration in patients with heart failure: <br>nasal high-flow oxygen therapy?<br> - Nasal high flow in heart failure patients with CSAS

niversitair Medisch Centrum Groningen0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • Moderate to severe central sleep apnoea (CSA)/Cheyne Stokes respiration (apnoea/hypopnoea index>15), in which CSA is defined when at least 50% of the apnoea*s are central apnoea*s
  • Heart failure diagnosed by cardiologist

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Other diseases affecting respiration during sleep (COPD GOLD 3 or 4, neuromuscular disorders, thorax cage deformities)
  • At the moment of the inclusion, the patient does not have a therapy to treat the CSA, such as CPAP, oxygen, BiPAP or acetazolamide.

研究者

相似试验

Treatment of central sleep apnoea and Cheyne Stokes... | 临床试验